Loading…
Based on limited metadata, the FDA issued a Warning Letter to Taiwan Biotech Co., LTD. on May 31, 2018, regarding an unspecified product category classified as "Other." Without access to the full letter text or subject line, the specific nature of the regulatory violations cannot be determined. The issuing office is also not documented in the available metadata, limiting clarity on the regulatory scope and product jurisdiction involved in this enforcement action.